Protein biomarkers for response to XPO1 inhibition in haematologic malignancies.
J Cell Mol Med
; 27(4): 587-590, 2023 02.
Article
in En
| MEDLINE
| ID: mdl-36722323
Key words
Full text:
1
Database:
MEDLINE
Main subject:
Hematologic Neoplasms
/
Multiple Myeloma
Type of study:
Prognostic_studies
Limits:
Humans
Language:
En
Journal:
J Cell Mol Med
Journal subject:
BIOLOGIA MOLECULAR
Year:
2023
Type:
Article
Affiliation country:
United States